Skip to main content
Top

Drugs

Issue 6/2020

Content (9 Articles)

Targeted Treatment for Erythrodermic Psoriasis: Rationale and Recent Advances

Shuai Shao, Gang Wang, Emanual Maverakis, Johann E. Gudjonsson

Advances in Long-Acting Agents for the Treatment of HIV Infection

Aadia I. Rana, Jose R. Castillo-Mancilla, Karen T. Tashima, Raphael L. Landovitz

A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain

Harrison Dermer, Daniella Lent-Schochet, Despoina Theotoka, Christian Paba, Abdullah A. Cheema, Ryan S. Kim, Anat Galor

Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial

Mala Dharmalingam, S. R. Aravind, Hemant Thacker, S. Paramesh, Brij Mohan, Manoj Chawla, Arthur Asirvatham, Ramesh Goyal, Jayashri Shembalkar, R. Balamurugan, Pradnya Kadam, Hansraj Alva, Rahul Kodgule, Monika Tandon, Sivakumar Vaidyanathan, Amol Pendse, Rajesh Gaikwad, Sagar Katare, Sachin Suryawanshi, Hanmant Barkate

Delgocitinib: First Approval

Sohita Dhillon

Tislelizumab: First Approval

Arnold Lee, Susan J. Keam

Remimazolam: First Approval

Susan J. Keam

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images